Article info

Original research
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks

Authors

  1. Correspondence to Dr Nick Ballew; nick.g.ballew{at}gsk.com
View Full Text

Citation

Neupane B, Shukla P, Slim M, et al
Belimumab versus anifrolumab in adults with systemic lupus erythematosus: an indirect comparison of clinical response at 52 weeks

Publication history

  • Received January 27, 2023
  • Accepted April 6, 2023
  • First published May 5, 2023.
Online issue publication 
May 05, 2023
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.